66 research outputs found
Clinical attachment loss and molecular profile of inflamed sites before treatment
Objective: To monitor early periodontal disease progression and to investigate clinical and molecular profile of inflamed sites by means of crevicular fluid and gingival biopsy analysis. Methodology: Eighty-one samples of twenty-seven periodontitis subjects and periodontally healthy individuals were collected for the study. Measurements of clinical parameters were recorded at day −15, baseline and 2 months after basic periodontal treatment aiming at monitoring early variations ofthe clinical attachment level. Saliva, crevicular fluid and gingival biopsies were harvested from clinically inflamed and non-inflamed sites from periodontal patients and from control sites of healthy patients for the assessment of IL-10, MMP-8, VEGF, RANKL, OPG and TGF-β1 protein and gene expression levels.
Results:Baseline IL-10 protein levels from inflamed sites were higher in comparison to both non-inflamed and control sites (p<0.05). Higher expression of mRNA for IL-10, RANK-L, OPG, e TGF-β1 were also observed in inflamed sites at day −15 prior treatment (p<0.05). After the periodontal treatment and the resolution of inflammation, seventeen percent of evaluated sites still showed clinically detectable attachment loss without significant differences in the molecular profile. Conclusions: Clinical attachment loss is a negative event that may occur even after successful basic periodontal therapy, but it is small and limited to a small percentage of sites. Elevated inflammation markers of inflamed sites from disease patients reduced to the mean levels of those observed in healthy subjects after successful basic periodontal therapy. Significantly elevated both gene and protein levels of IL-10 in inflamed sites prior treatment confirms its modulatory role in the disease status
New tendencies in non-surgical periodontal therapy
The aim of this review was to update the evidence of new approaches to non-surgical therapy (NSPT) in the treatment of periodontitis. Preclinical and clinical studies addressing the benefits of adjunctive antimicrobial photodynamic therapy, probiotics, prebiotics/synbiotics, statins, pro-resolving mediators, omega-6 and -3, ozone, and epigenetic therapy were scrutinized and discussed. Currently, the outcomes of these nine new approaches, when compared with subgingival debridement alone, did not demonstrate a significant added clinical benefit. However, some of these new alternative interventions may have the potential to improve the outcomes of NSPT alone. Future evidence based on randomized controlled clinical trials would help clinicians and patients in the selection of different adjunctive therapies
Bifidobacterium animalis subsp lactis HN019 presents antimicrobial potential against periodontopathogens and modulates the immunological response of oral mucosa in periodontitis patients
Objective To evaluate the effects of Bifidobacterium animalis subsp. lactis HN019 (HN019) on clinical periodontal parameters (plaque accumulation and gingival bleeding), on immunocompetence of gingival tissues [expression of beta-defensin (BD)-3, toll-like receptor 4 (TLR4), cluster of differentiation(CD)-57 and CD-4], and on immunological properties of saliva (IgA levels) in non-surgical periodontal therapy in generalized chronic periodontitis (GCP) patients. Adhesion to buccal epithelial cells (BEC) and the antimicrobial properties of HN019 were also investigated. Materials and methods Thirty patients were recruited and monitored clinically at baseline (before scaling and root planing-SRP) and after 30 and 90 days. Patients were randomly assigned to Test (SRP +Probiotic, n = 15) or Control (SRP+Placebo, n = 15) group. Probiotic lozenges were used for 30 days. Gingival tissues and saliva were immunologically analyzed. The adhesion of HN019 with or without Porphyromonas gingivalis in BEC and its antimicrobial properties were investigated in in vitro assays. Data were statistically analyzed (p<0.05). Results Test group presented lower plaque index (30 days) and lower marginal gingival bleeding (90 days) when compared with Control group. Higher BD-3, TLR4 and CD-4 expressions were observed in gingival tissues in Test group than in Control group. HN019 reduced the adhesion of P. gingivalis to BEC and showed antimicrobial potential against periodontopathogens. Conclusion Immunological and antimicrobial properties of B. lactis HN019 make it a potential probiotic to be used in non-surgical periodontal therapy of patients with GCP.Fil: Invernici, Marcos M.. Universidade de Sao Paulo; BrasilFil: Furlaneto, Flávia A. C.. Universidade de Sao Paulo; BrasilFil: Salvador, Sérgio L. Universidade de Sao Paulo; BrasilFil: Ouwehand, Arthur C.. Dupont, Nutrition and Health; FinlandiaFil: Salminen, Seppo. University of Turku. Functional Foods Forum; FinlandiaFil: Mantziari, Anastasia. University of Turku. Functional Foods Forum; FinlandiaFil: Vinderola, Celso Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; ArgentinaFil: Ervolino, Edilson. São Paulo State University. Division of Histology, Department of Basic Sciences, Dental School of Araçatuba; BrasilFil: Santana, Sandro Isaías. Universidade de Sao Paulo; BrasilFil: Silva, Pedro Henrique Felix. Universidade de Sao Paulo; BrasilFil: Messora, Michel R.. Universidade de Sao Paulo; Brasi
Effects of platelet-rich fibrin produced by three centrifugation protocols on bone neoformation in defects created in rat calvaria.
This study evaluated the potential of Leukocyte-platelet-rich fibrin (L-PRF; fixed angle centrifugation protocol), Advanced-platelet-rich fibrin (A-PRF; low-speed fixed angle centrifugation protocol), and Horizontal-platelet-rich fibrin (H-PRF; horizontal centrifugation protocol) in bone neoformation in critical size defects (CSDs) in rat calvaria. Thirty-two rats were divided into groups: Control (C), L-PRF, A-PRF, and H-PRF. 5 mm diameter CSDs were created in the animals' calvaria. Defects from group Control (C) were filled with blood clots, while defects from groups L-PRF, A-PRF, and H-PRF were filled with respective platelet-rich fibrin (PRF) membranes. L-PRF, A-PRF, and H-PRF were prepared from animal blood collection and specific centrifugation protocols. At 14 and 30 days, calcein (CA) and alizarin (AL) injections were performed, respectively. Animals were euthanized at 35 days. Microtomographic, laser confocal microscopy, and histomorphometric analyzes were performed. Data were statistically analyzed (ANOVA, Tukey, p < .05). L-PRF, A-PRF, and H-PRF groups showed higher values of bone volume (BV), newly formed bone area (NFBA), and precipitation of CA and AL than the C group (p < .05). The H-PRF group showed higher values of BV, number of trabeculae (Tb. N), NFBA, and higher precipitation of AL than the A-PRF and L-PRF groups (p < .05). Therefore, it can be concluded that: i) L-PRF, A-PRF, and H-PRF potentiate bone neoformation in CSDs in rat calvaria; ii) H-PRF demonstrated more biological potential for bone healing
Bifidobacterium animalis subsp lactis HN019 presents antimicrobial potential against periodontopathogens and modulates the immunological response of oral mucosa in periodontitis patients
Objective To evaluate the effects of Bifidobacterium animalis subsp. lactis HN019 (HN019) on clinical periodontal parameters (plaque accumulation and gingival bleeding), on immunocompetence of gingival tissues [expression of beta-defensin (BD)-3, toll-like receptor 4 (TLR4), cluster of differentiation(CD)-57 and CD-4], and on immunological properties of saliva (IgA levels) in non-surgical periodontal therapy in generalized chronic periodontitis (GCP) patients. Adhesion to buccal epithelial cells (BEC) and the antimicrobial properties of HN019 were also investigated. Materials and methods Thirty patients were recruited and monitored clinically at baseline (before scaling and root planing—SRP) and after 30 and 90 days. Patients were randomly assigned to Test (SRP+Probiotic, n = 15) or Control (SRP+Placebo, n = 15) group. Probiotic lozenges were used for 30 days. Gingival tissues and saliva were immunologically analyzed. The adhesion of HN019 with or without Porphyromonas gingivalis in BEC and its antimicrobial properties were investigated in in vitro assays. Data were statistically analyzed (p</p
Cicatrização de enxertos de osso alógeno fresco congelado (OAFC) associados ou não ao plasma rico em plaquetas (PRP): estudo histológico e histométrico em mandíbulas de cães
O propósito deste estudo foi avaliar, histologicamente, a cicatrização de enxertos de osso alógeno fresco congelado (OAFC) associados ou não ao plasma rico em plaquetas (PRP) em defeitos ósseos criados cirurgicamente em mandíbulas de cães. Defeitos ósseos bilaterais, medindo 1,5 cm de largura x 1 cm de altura, foram criados na borda inferior da mandíbula de 10 cães adultos machos. Os defeitos foram divididos em 3 grupos experimentais: C (controle), OAFC, OAFC/PRP. No Grupo C (n=7), os defeitos foram preenchidos apenas com coágulo sangüíneo. No Grupo OAFC (n=7), os defeitos foram preenchidos com enxertos de OAFC. No Grupo OAFC/PRP (n=6), os defeitos foram preenchidos com enxertos de OAFC associados ao PRP. A eutanásia dos animais foi realizada em 12 semanas pós-operatórias. Foram realizadas análises histológica e histométrica. Os dados foram analisados estatisticamente (ANOVA, Tukey, p < 0,05). Nenhum defeito regenerou completamente com tecido ósseo. Os enxertos de OAFC foram bem incorporados. A quantidade média de osso neoformado e os desvios-padrão dos Grupos C, OAFC e OAFC/PRP foram 70,55 8,01%, 71,31 14,36% e 65,57 11,55%, respectivamente. Não foram observadas diferenças estatisticamente significativas entre os grupos (ANOVA, p = 0,642). Os enxertos de OAFC foram biocompatíveis e bem incorporados, mas não proporcionaram maior formação óssea que os defeitos controle em mandíbulas de cães. O uso do PRP não promoveu nenhum benefício adicional à cicatrização desses enxertos em 12 semanas pós-operatórias.The purpose of this study was to histologically analyze the healing of fresh frozen bone allograft (FFBA) with or without platelet-rich plasma (PRP) in bony defects surgically created in mandible of dogs. Bilateral bony defects, measuring 1.5 cm in width vs. 1 cm in height, were created in the inferior border of the mandible of 10 adult male dogs. The defects were divided into three groups: C (control), FFBA and FFBA/PRP. In Group C (n=7), the defect was filled with blood clot only. In Group FFBA (n=7), the defect was filled with FFBA. In Group FFBA/PRP (n=6), the defect was filled with FFBA combined with PRP. All animals were euthanized at 12 weeks post-operative. Histologic and histometric analyses were performed. Data were statistically analyzed (ANOVA, Tukey, p < 0.05). No defect completely regenerated with bone. The FFBA was well incorporated. The mean percentage of newly formed bone and the standard-deviations of Groups C, FFBA and FFBA/PRP were 70.55 8.01%, 71.31 14.36% and 65.57 11.55%, respectively. Statistically significant differences were not found among the groups (ANOVA, p = 0,642). FFBA were biocompatible and well incorporated. However, these grafts did not promote a greater bone formation than the control defects in mandible of dogs. The use of PRP promoted no additional benefit to the healing of these grafts at 12 weeks post-operative
Chronological analysis of periodontal bone loss in experimental periodontitis in mice
Abstract Objectives Periodontal disease is understood to be a result of dysbiotic interactions between the host and the biofilm, causing a unique reaction for each individual, which in turn characterizes their susceptibility. The objective of this study was to chronologically evaluate periodontal tissue destruction induced by systemic bacterial challenge in known susceptible (BALB/c) and resistant (C57BL/6) mouse lineages. Material and Methods Animals, 6–8 weeks old, were allocated into three experimental groups: Negative control (C), Gavage with sterile carboxymethyl cellulose 2%—without bacteria (Sham), and Gavage with carboxymethyl cellulose 2% + Porphyromonas gingivalis (Pg‐W83). Before infection, all animals received antibiotic treatment (sulfamethoxazole/trimethoprim, 400/80 mg/5 mL) for 7 days, followed by 3 days of rest. Microbial challenge was performed 3 times per week for 1, 2, or 3 weeks. After that, the animals were kept until the completion of 42 days of experiments, when they were euthanized. The alveolar bone microarchitecture was assessed by computed microtomography. Results Both C57BL/6 and BALB/c mice exhibited significant bone volume loss and lower trabecular thickness as well as greater bone porosity compared to the (C) and (Sham) groups after 1 week of microbial challenge (p < .001). When comparing only the gavage groups regarding disease implantation, time and lineage, it was possible to observe that within 1 week of induction the disease was more established in BALB/c than in C57BL/6 (p < .05). Conclusions Our results reflected that after 1 week of microbial challenge, there was evidence of alveolar bone loss for both lineages, with the loss observed in BALB/c mice being more pronounced
- …